Sastra University, India
Author Profile
Early Academic Pursuits
Dr. Joy Debnath began his academic journey with a Bachelor of Science (B. Sc.) in Chemistry (Hons.), Physics, and Mathematics from Calcutta University, followed by a Master of Science (M. Sc.) in Chemistry with a specialization in Organic Chemistry from the same institution. He further pursued his academic aspirations with a Ph.D. in Chemistry from the prestigious Indian Institute of Technology, Kharagpur (IIT-KGP), where he focused on designing nucleoside-based inhibitors of Ribonuclease A and Angiogenin under the guidance of Prof. Tanmaya Pathak and Prof. Swagata Dasgupta.
Professional Endeavors
He has garnered extensive experience in academia and research. He has held positions as a Postdoctoral Fellow at the University of Tennessee and Wayne State University in the United States. Additionally, he served as a Research Trainee at Syngene International, Bangalore. Currently, he holds the position of Associate Professor at SASTRA University, Tamil Nadu, where he has been actively involved in teaching and research since April 2012.
Contributions and Research Focus
Throughout his career, He has made significant contributions to the field of chemistry, particularly in the design and synthesis of nucleoside-based inhibitors. His research focus includes medicinal chemistry, chemical biology, and organic synthesis. His Ph.D. thesis on designing inhibitors of Ribonuclease A and Angiogenin reflects his expertise in the development of novel therapeutic agents.
Accolades and Recognition
Dr. Debnath has been recognized for his academic and research achievements. He has received prestigious awards and fellowships such as the CSIR-NET, UGC-NET, and GATE, acknowledging his excellence in the field of chemistry. These accolades underscore his commitment to scholarly pursuits and academic excellence.
Impact and Influence
His research has had a significant impact on the field of medicinal chemistry, contributing to the development of potential therapeutic agents targeting important biological molecules. His work has the potential to lead to the discovery of novel drugs for the treatment of various diseases, thus positively influencing the field of healthcare and pharmaceuticals.
Legacy and Future Contributions
As He continues his academic and research endeavors, his legacy of excellence and dedication to advancing the frontiers of chemistry is poised to inspire future generations of scientists and researchers. His ongoing research efforts hold the promise of addressing unmet medical needs and making significant contributions to the field of medicinal chemistry. Through his academic achievements, professional endeavors, and research contributions, Dr. Joy Debnath exemplifies a commitment to excellence in the field of chemistry and serves as a role model for aspiring researchers in the scientific community.
A total of 512 citations for his publications, demonstrating the impact and recognition of his research within the academic community.
- Citations 512
- h-index 12
- i10-index 17
Notable Publications
Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis
J Debnath, S Siricilla, B Wan, DC Crick, AJ Lenaerts, SG Franzblau, ...
[131] 2012
Binding of all-trans retinoic acid to human serum albumin: fluorescence, FT-IR and circular dichroism studies
TK Maiti, KS Ghosh, J Debnath, S Dasgupta
[71] 2006
Eugenol derived immunomodulatory molecules against visceral leishmaniasis
MRC Raja, AB Velappan, D Chellappan, J Debnath, SK Mahapatra
[45] 2017
Inhibition of ribonuclease A by polyphenols present in green tea
KS Ghosh, TK Maiti, J Debnath, S Dasgupta
[25] 2007
Successful medical treatment of emphysematous pyelonephritis in a renal allograft recipient
KV Baliga, AS Narula, A Sharma, R Khanduja, M Manrai, J Debnath, ...
[22] 2007
Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S, 6S)-6-benzhydryltetrahydro-2H-pyran-3-yl) amino) methyl) phenol: Synthesis, biological characterization …
H Sharma, S Santra, J Debnath, T Antonio, M Reith, A Dutta
[19] 2014
Oral administration of eugenol oleate cures experimental visceral leishmaniasis through cytokines abundance
MRC Raja, A Kar, S Srinivasan, D Chellappan, J Debnath, SK Mahapatra
[18] 2021
Nucleoside–amino acid conjugates: An alternative route to the design of ribonuclease A inhibitors
J Debnath, S Dasgupta, T Pathak
[17] 2009
Inhibition of copper-mediated aggregation of human γD-crystallin by Schiff bases
P Chauhan, SB Muralidharan, AB Velappan, D Datta, S Pratihar, ...
[16] 2017
Dinucleosides with Non‐Natural Backbones: A New Class of Ribonuclease A and Angiogenin Inhibitors
J Debnath, S Dasgupta, T Pathak
[16] 2012